Management of Diabetes and Cardiovascular Comorbidities

Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Muthiah Vaduganathan, MD, MPH, provide an overview of cardiovascular comorbidities in patients with diabetes.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses goals of therapy in diabetic patients with cardiovascular disease and Robert Busch, MD, provides an overview of diabetes treatment guidelines.

Muthiah Vaduganathan, MD, MPH, provides insight into cardiology guidelines for the use of SGLT-2 [sodium-glucose cotransporter-2] inhibitors and GLP-1 [glucagon-like peptide-1] receptor agonists and discusses the uptake of these medications in patients with and without diabetes.

A panel of experts discuss their experience with multidisciplinary collaboration of care between primary care physicians, cardiologists, endocrinologists, and pharmacists in patients with diabetes and cardiovascular disease.

Robert Busch, MD, provides an overview of the clinical trials supporting improved cardiovascular disease outcomes in patients with and without diabetes.

A panel of experts provide clinical pearls for primary care providers who manage patients with diabetes and cardiovascular comorbidities.

Muthiah Vaduganathan, MD, MPH, presents a case study for a patient hospitalized with heart failure whose therapy was optimized with an SGLT-2 inhibitor.